Literature DB >> 19100774

Therapeutic peptide vaccines for treatment of autoimmune diseases.

David C Wraith1.   

Abstract

Recent advances in immunology have led to exciting new possibilities in medicine. We now understand how to design vaccine capable of resetting the balance between immune effector and regulatory cells in people suffering from autoimmune and allergic diseases. These approaches are effective while avoiding the side effects associated with non-specific immune suppression.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19100774      PMCID： PMC2657787          DOI： 10.1016/j.imlet.2008.11.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


  17 in total

Review 1.  Oral tolerance: mechanisms and therapeutic applications.

Authors:  A M Faria; H L Weiner
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Authors:  Abdelilah Wakkach; Nathalie Fournier; Valérie Brun; Jean-Philippe Breittmayer; Françoise Cottrez; Hervé Groux
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

4.  Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.

Authors:  Anette Sundstedt; Emma J O'Neill; Kirsty S Nicolson; David C Wraith
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

5.  IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.

Authors:  Pedro L Vieira; Jillian R Christensen; Sophie Minaee; Emma J O'Neill; Franck J Barrat; André Boonstra; Thomas Barthlott; Brigitta Stockinger; David C Wraith; Anne O'Garra
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

6.  Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin.

Authors:  S M Anderton; D C Wraith
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

7.  Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.

Authors:  N J Viner; C A Nelson; B Deck; E R Unanue
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

8.  Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.

Authors:  M Peakman; E J Stevens; T Lohmann; P Narendran; J Dromey; A Alexander; A J Tomlinson; M Trucco; J C Gorga; R M Chicz
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 9.  Regulatory CD4+ T cells and the control of autoimmune disease.

Authors:  David C Wraith; Kirsty S Nicolson; Nathaniel T Whitley
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

10.  Interleukin-10 production by effector T cells: Th1 cells show self control.

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307
View more
  19 in total

Review 1.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

2.  Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor.

Authors:  Ahmed H Badawi; Paul Kiptoo; Wen-Tung Wang; In-Young Choi; Phil Lee; Charlotte M Vines; Teruna J Siahaan
Journal:  Neuropharmacology       Date:  2011-12-17       Impact factor: 5.250

3.  IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.

Authors:  Duncheng Wang; Debjani Ghosh; S M Touhidul Islam; Cody D Moorman; Ashton E Thomason; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

4.  Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.

Authors:  Himgauri Naik; Ted Gauthier; Sitanshu Singh; Seetharama Jois
Journal:  Bioorg Med Chem Lett       Date:  2018-10-03       Impact factor: 2.823

Review 5.  Peptides and peptidomimetics as immunomodulators.

Authors:  Ameya S Gokhale; Seetharama Satyanarayanajois
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC.

Authors:  Barlas Büyüktimkin; Prakash Manikwar; Paul K Kiptoo; Ahmed H Badawi; John M Stewart; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2012-11-29       Impact factor: 4.939

7.  Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.

Authors:  V B Gibson; T Nikolic; V Q Pearce; J Demengeot; B O Roep; M Peakman
Journal:  Clin Exp Immunol       Date:  2015-09-17       Impact factor: 4.330

8.  Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro.

Authors:  Chuda Chittasupho; Joshua Sestak; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Mol Pharm       Date:  2013-12-04       Impact factor: 4.939

Review 9.  Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.

Authors:  E Zonneveld-Huijssoon; S Albani; B J Prakken; F van Wijk
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

Review 10.  Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.

Authors:  Rhoanne C McPherson; Stephen M Anderton
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-09       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.